WebWelcome to Cer-Met. Cer-Met, Inc. provides customer-focused sales and installation of world-class refractory materials to all industries. With an overall emphasis on safety and … WebOct 27, 2024 · Daratumumab monotherapy demonstrated favorable safety and efficacy in relapsed/refractory multiple myeloma (RRMM) patients in the global phase 1/2 GEN501 and phase 2 SIRIUS studies. MMY1003 evaluated daratumumab monotherapy specifically in Chinese patients with RRMM. This 3-part, open-label, phase 1 …
Anti-rituximab antibodies in patients with refractory ... - PubMed
WebFeb 21, 2024 · Super-refractory status epilepticus (SRSE) is a serious and life-threatening neurological condition. Ketogenic diet (KD) is a diet characterized by high fat, low carbohydrate, and moderate protein. As KD shows effectiveness in controlling seizures in more than half of SRSE patients, it can be a treatment option for SRSE. Currently, KD … WebBackground: Refractory esophageal stricture (RES) may be attributed to food allergy. Its etiology and pathogenesis are not fully understood. Identification of novel genetic variants associated with this disease by exome sequencing (exome-seq) may provide new mechanistic insights and new therapeutic targets. Methods: To identify new and novel … gassler \\u0026 company llc
List of Refractory Companies in China
WebChinaspar Metals & Minerals Co., Ltd (Chinaspar as below mentioned) is one of the leading manufacturers and exporters in refractory material, steel auxiliary ferro alloy chemical … WebFeb 8, 2024 · A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma. The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. WebNov 5, 2024 · In this presentation, we will report an updated analysis of orelabrutinib in Chinese patients with r/r MCL with minimum of 12 cycles of treatment. Aims: To evaluate the sustained efficacy and long-term safety of orelabrutinib in Chinese patients with r/r MCL. Methods: This is an open-label, multicenter, two stages, phase II study. The primary ... david martha borg